Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Updated on: January 04,2024
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Updated on:January 04,2024
